| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antagonism of the antinociceptive effects of fentanyl and the veterinary anesthetic xylazine in mice
|
Cakir, Kerim
|
|
|
392 |
4 |
p.
|
artikel
|
| 2 |
Antibody immunotherapies for personalized opioid addiction treatment
|
Rosenn, Eric H.
|
|
|
392 |
4 |
p.
|
artikel
|
| 3 |
Bazedoxifene plus conjugated estrogen to treat menopausal depression—A pilot study
|
Kulkarni, Jayashri
|
|
|
392 |
4 |
p.
|
artikel
|
| 4 |
cAMP response element–binding protein: A credible cancer drug target
|
Hong, Jinghui
|
|
|
392 |
4 |
p.
|
artikel
|
| 5 |
Coculture of mesenchymal stem cells and macrophage: A narrative review
|
Ning, Jun
|
|
|
392 |
4 |
p.
|
artikel
|
| 6 |
Commentary: Behavior as an important determinant of drug action
|
Barrett, James E.
|
|
|
392 |
4 |
p.
|
artikel
|
| 7 |
Cover
|
|
|
|
392 |
4 |
p.
|
artikel
|
| 8 |
DBeQ derivative targets vacuolar protein sorting 4 functions in cancer cells and suppresses tumor growth in mice
|
Fundora, Kevin A.
|
|
|
392 |
4 |
p.
|
artikel
|
| 9 |
Discovery of ZYDG2: A potent, selective, and safe GPR40 agonist for treatment of type 2 diabetes
|
Jain, Mukul R.
|
|
|
392 |
4 |
p.
|
artikel
|
| 10 |
Effects and molecular mechanisms of farnesyltransferase inhibitor tipifarnib on platelet activation
|
Chaudhary, Preeti K.
|
|
|
392 |
4 |
p.
|
artikel
|
| 11 |
Kaempferol attenuates macrophage M1 polarization and liver fibrosis by inhibiting mitogen-activated protein kinase/nuclear factor κB signaling pathway
|
Chen, Jiajia
|
|
|
392 |
4 |
p.
|
artikel
|
| 12 |
Managing thrombus formation with EL2-5HTVac: A selective vaccination-based approach targeting the platelet serotonin 5-HT2AR
|
Alarabi, Ahmed B.
|
|
|
392 |
4 |
p.
|
artikel
|
| 13 |
Menopause-related changes in vascular signaling by sex hormones
|
Li, Tao
|
|
|
392 |
4 |
p.
|
artikel
|
| 14 |
Metabolomic and lipidomic profiling reveals convergent pathways in attention deficit hyperactivity disorder therapeutics: Insights from established and emerging treatments
|
Grzymala, Bartosz
|
|
|
392 |
4 |
p.
|
artikel
|
| 15 |
Morphine-induced hyperalgesia impacts small extracellular vesicle microRNA composition and function
|
Reddy, Deepa
|
|
|
392 |
4 |
p.
|
artikel
|
| 16 |
Predicting the effects of single pathological mutations in hemophilia A and type 2N von Willebrand diseases using AlphaFold2-multimer and AlphaFold3
|
Zhang, Ziyu
|
|
|
392 |
4 |
p.
|
artikel
|
| 17 |
Preliminary pharmacokinetics and in vivo studies indicate analgesic and stress mitigation effects of a novel NMDA receptor modulator
|
Costa, Blaise M.
|
|
|
392 |
4 |
p.
|
artikel
|
| 18 |
Retraction notice to “Development of Angiotensin IV Analogs as Hepatocyte Growth Factor/Met Modifiers” [J Pharmacol Exp Ther 340 (2012) 539-548]
|
Kawas, Leen H.
|
|
|
392 |
4 |
p.
|
artikel
|
| 19 |
Retraction notice to “Mimics of the Dimerization Domain of Hepatocyte Growth Factor Exhibit Anti-Met and Anticancer Activity” [J Pharmacol Exp Ther 339 (2011) 509-518]
|
Kawas, Leen H.
|
|
|
392 |
4 |
p.
|
artikel
|
| 20 |
Retraction notice to “Mitigation of Nitrogen Mustard–Induced Skin Injury by the β-Blocker Carvedilol and Its Enantiomers” [J Pharmacol Exp Ther 388 (2024) 495-505]
|
Shahid, Ayaz
|
|
|
392 |
4 |
p.
|
artikel
|
| 21 |
Retraction notice to “The Procognitive and Synaptogenic Effects of Angiotensin IV–Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System” [J Pharmacol Exp Ther 351 (2014) 390-402]
|
Benoist, Caroline C.
|
|
|
392 |
4 |
p.
|
artikel
|
| 22 |
γ-Secretase modulation inhibits amyloid plaque formation and growth and stimulates plaque regression in amyloid precursor protein/presenilin-1 mice
|
Nordvall, Gunnar
|
|
|
392 |
4 |
p.
|
artikel
|
| 23 |
Small molecule interleukin (IL) 17A/A antagonists and antibodies blocking both IL17A/A and IL17A/F demonstrate equivalent degrees of efficacy in preclinical models of skin and joint inflammation
|
Goedken, Eric R.
|
|
|
392 |
4 |
p.
|
artikel
|
Tijdschrift beschrijving